PJ

Pokattu Janardhanan Mukesh

Active Director Director DIN 11389003
DIN 11389003 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pokattu Janardhanan Mukesh

Data last updated:

Pokattu Janardhanan Mukesh is a Director at Phorvia Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11389003
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Phorvia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pokattu Janardhanan Mukesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pokattu Janardhanan Mukesh

Pokattu Janardhanan Mukesh currently holds 1 directorship: Phorvia Pharmaceuticals Private Limited (Director, since 20 Nov 2025).

Pokattu Janardhanan Mukesh was first appointed on 20 Nov 2025 as Director at Phorvia Pharmaceuticals Private Limited.

The current boards of Pokattu Janardhanan Mukesh's companies include Abdul Azeez Kavunga Parambil (Phorvia Pharmaceuticals Private Limited), Jithendra Palakkal (Phorvia Pharmaceuticals Private Limited), Rajeev (Phorvia Pharmaceuticals Private Limited), Saran Karayi Raghavan (Phorvia Pharmaceuticals Private Limited), Sudheer Mohamed Sultan (Phorvia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available